[Form 4] Lite Strategy, Inc. Insider Trading Activity
Lite Strategy, Inc. (LITS) reported an equity award to one of its directors in the form of stock options. On 11/14/2025, the director received an option grant covering 55,000 shares of common stock at an exercise price of $2.02 per share. These options are a customary annual grant to non-employee directors and were received as compensation for board service. The options vest over time, with 16.66666% vesting on the grant date and the remaining portion vesting in equal monthly amounts beginning 12/14/2025 and continuing through 11/14/2026, encouraging ongoing alignment between the director’s interests and those of shareholders.
- None.
- None.
FAQ
What equity award was reported for Lite Strategy, Inc. (LITS) on this Form 4?
The filing reports that a Lite Strategy, Inc. director received a stock option grant to purchase 55,000 shares of common stock at an exercise price of $2.02 per share.
When was the stock option grant to the Lite Strategy (LITS) director made?
The stock option grant to the director was made on 11/14/2025, which is shown as the earliest transaction date on the Form 4.
What is the vesting schedule for the 55,000 Lite Strategy (LITS) stock options?
The options vest as follows: 16.66666% vest on the grant date, and the remaining shares vest in equal monthly amounts starting on 12/14/2025 and continuing on the first day of each month through 11/14/2026.
Why did the Lite Strategy (LITS) director receive these stock options?
The options were described as a customary annual grant to non-employee directors and were received as compensation for service on the Board of Lite Strategy, Inc.
What type of security underlies the reported stock options for Lite Strategy (LITS)?
The derivative security is a stock option (right to buy), and the security underlying the option is Lite Strategy, Inc. common stock, with 55,000 shares underlying the option.
What is the expiration date of the Lite Strategy (LITS) director’s stock options?
The reported stock options have an expiration date of 11/14/2035, giving a long-term window for potential exercise.